Skip to main content

Young Min Cho

Seoul National University · 医学

研究室紹介

Professor Young Min Cho's research lab focuses on metabolic diseases, particularly type 2 diabetes and insulin resistance, with an emphasis on identifying novel biomarkers and therapeutic targets. The lab investigates the roles of adipokines such as RBP4, incretin hormones like GLP-1, and the impact of pharmacological agents—including SGLT2 and DPP4 inhibitors—on metabolic and renal health. Additionally, the lab explores mitochondrial transfer mechanisms in cellular repair and the genetic architecture underlying complex traits, such as carcass weight in Hanwoo cattle, using advanced genomics approaches. These interdisciplinary efforts integrate molecular biology, translational medicine, and systems genetics to advance diabetes therapeutics and metabolic disease understanding.

type 2 diabetesadipokinesSGLT2 inhibitorsGLP-1genetic association studies

Research Overview

Papers
464
Total Citations
14,073
Papers (5y)
99
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
99total
2022
2023
2024
2025
2026
Citations per year (5y)
956total
20222023202420252026

Selected Papers

15
1
Article|467 citations·2006
Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells
Young Min Cho, Sujin Kwon, Youngmi Kim Pak, Hye Won Seol, Young Min Choi, Do Joon Park, Kyong Soo Park, Hong Kyu Lee
SJR Q2Biochemical and Biophysical Research Communications
Molecular BiologyBiochemistry, Genetics and Molecular Biology
2
Article|399 citations·2006
Plasma Retinol-Binding Protein-4 Concentrations Are Elevated in Human Subjects With Impaired Glucose Tolerance and Type 2 Diabetes
Young Min Cho, Byung‐Soo Youn, Hyewon Lee, Namseok Lee, Sung-Shik Min, Soo Heon Kwak, Hong Kyu Lee, Kyong Soo Park
SJR Q1Diabetes CareOA

OBJECTIVE: The dysregulation of adipokines is closely associated with the pathogenesis of insulin resistance and type 2 diabetes. Retinol-binding protein-4 (RBP4), a new adipokine, was recently reported to provide a link between obesity and insulin resistance. Here, we examined the relation between plasma RBP4 concentrations and various metabolic parameters in humans. RESEARCH DESIGN AND METHODS: An enzyme-linked immunosorbent assay was developed to measure human RBP4 plasma concentrations, whic

Molecular BiologyBiochemistry, Genetics and Molecular Biology
3
Review|174 citations·2013
Glucagon-Like Peptide-1: Glucose Homeostasis and Beyond
Young Min Cho, Yukihiro Fujita, Timothy J. Kieffer
SJR Q1Annual Review of PhysiologyOA

Glucagon-like peptide-1 (GLP-1), an incretin hormone secreted primarily from the intestinal L-cells in response to meals, modulates nutrient homeostasis via actions exerted in multiple tissues and cell types. GLP-1 and its analogs, as well as compounds that inhibit endogenous GLP-1 breakdown, have become an effective therapeutic strategy for many subjects with type 2 diabetes. Here we review the discovery of GLP-1; its synthesis, secretion, and elimination from the circulation; and its multiple

Endocrinology, Diabetes and MetabolismMedicine
4
Article|174 citations·2012
Mesenchymal Stem Cells Transfer Mitochondria to the Cells with Virtually No Mitochondrial Function but Not with Pathogenic mtDNA Mutations
Young Min Cho, Ju Han Kim, Mingoo Kim, Su Jin Park, Sang Hyeok Koh, Hyo Seop Ahn, Gyeong Hoon Kang, Jung Bin Lee, Kyong Soo Park, Hong-Kyu Lee
SJR Q1PLoS ONEOA

It has been reported that human mesenchymal stem cells (MSCs) can transfer mitochondria to the cells with severely compromised mitochondrial function. We tested whether the reported intercellular mitochondrial transfer could be replicated in different types of cells or under different experimental conditions, and tried to elucidate possible mechanism. Using biochemical selection methods, we found exponentially growing cells in restrictive media (uridine(-) and bromodeoxyuridine [BrdU](+)) during

Molecular BiologyBiochemistry, Genetics and Molecular Biology
5
Review|141 citations·2012
Targeting the glucagon receptor family for diabetes and obesity therapy
Young Min Cho, Catherine E. Merchant, Timothy J. Kieffer
SJR Q1Pharmacology & Therapeutics
Endocrinology, Diabetes and MetabolismMedicine
6
Article|123 citations·2007
Improvement in hydrogen sorption kinetics of MgH2 with Nb hydride catalyst
Sheng Jin, Jongwon Shim, Jong‐Hyun Ahn, Young Min Cho, Kyung‐Woo Yi
SJR Q1Acta Materialia
Materials ChemistryMaterials Science
7
Article|109 citations·2013
Genome-Wide Association Study Identifies Major Loci for Carcass Weight on BTA14 in Hanwoo (Korean Cattle)
Seung Hwan Lee, Bong‐Hwan Choi, Dajeong Lim, Cedric Gondro, Young Min Cho, Chang–Gwon Dang, Aditi Sharma, Gul Won Jang, Kyung‐Tai Lee, Duhak Yoon, Hak‐Kyo Lee, Seong Heum Yeon
SJR Q1PLoS ONEOA

This genome-wide association study (GWAS) was conducted to identify major loci that are significantly associated with carcass weight, and their effects, in order to provide increased understanding of the genetic architecture of carcass weight in Hanwoo. This genome-wide association study identified one major chromosome region ranging from 23 Mb to 25 Mb on chromosome 14 as being associated with carcass weight in Hanwoo. Significant Bonferroni-corrected genome-wide associations (P<1.52×10(-6)) we

GeneticsBiochemistry, Genetics and Molecular Biology
8
Article|99 citations·2021
Sodium‐glucose cotransporter‐2 inhibition reduces cellular senescence in the diabetic kidney by promoting ketone body‐induced NRF2 activation
Mi Na Kim, Joon Ho Moon, Young Min Cho
SJR Q1Diabetes Obesity and Metabolism

Abstract Aims To evaluate whether sodium‐glucose cotransporter‐2 (SGLT2) inhibition reduces cellular senescence in the kidney and to investigate the molecular pathways involved in the renoprotective effect. Materials and methods Dapagliflozin (1 mg/kg), glimepiride (2.5 mg/kg) or vehicle was administered daily via oral gavage for 8 weeks in db/db mice. Expression levels of ageing marker genes (p21, p16, and p53) and oxidative stress were measured in the kidney using real‐time RT‐PCR, immunohisto

Endocrinology, Diabetes and MetabolismMedicine
9
Review|91 citations·2010
K-cells and Glucose-Dependent Insulinotropic Polypeptide in Health and Disease
Young Min Cho, Timothy J. Kieffer
Vitamins and hormones
Endocrinology, Diabetes and MetabolismMedicine
10
Review|84 citations·2016
Comparison between SGLT2 inhibitors and DPP4 inhibitors added to insulin therapy in type 2 diabetes: a systematic review with indirect comparison meta‐analysis
Se Hee Min, Jeong‐Hwa Yoon, Seokyung Hahn, Young Min Cho
SJR Q1Diabetes/Metabolism Research and ReviewsOA

BACKGROUND: Both sodium glucose cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP4) inhibitors can be used to treat patients with type 2 diabetes mellitus (T2DM) that is inadequately controlled with insulin therapy, and yet there has been no direct comparison of these two inhibitors. METHODS: We searched MEDLINE, EMBASE, LILACS, the Cochrane Central Register of Controlled Trials and ClinicalTrials.gov through June 2015. Randomized controlled trials published in English that comp

Endocrinology, Diabetes and MetabolismMedicine
11
Review|73 citations·2014
Incretin physiology and pathophysiology from an Asian perspective
Young Min Cho
SJR Q1Journal of Diabetes InvestigationOA

Incretin hormones, such as glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1, are secreted on oral nutrient ingestion and regulate postprandial glucose homeostasis by conveying the signal of intestinal glucose flux. In East Asians, the secretion of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 is not reduced in type 2 diabetes relative to normal glucose tolerance. Although the incretin effect is blunted in European patients with type 2 diabetes,

Endocrinology, Diabetes and MetabolismMedicine
12
Article|68 citations·2007
Betacellulin and nicotinamide sustain PDX1 expression and induce pancreatic β-cell differentiation in human embryonic stem cells
Young Min Cho, Jung Mee Lim, Dae Hoon Yoo, Jae Hyeon Kim, Sung Soo Chung, Sanggyu Park, Tae Hyuk Kim, Sun Kyung Oh, Young Min Choi, Shin Yong Moon, Kyong Soo Park, Hong Kyu Lee
SJR Q2Biochemical and Biophysical Research Communications
SurgeryMedicine
13
Article|66 citations·2018
The Effect of a Smartphone-Based, Patient-Centered Diabetes Care System in Patients With Type 2 Diabetes: A Randomized, Controlled Trial for 24 Weeks
Eun Ky Kim, Soo Heon Kwak, Hye Seung Jung, Bo Kyung Koo, Min Kyong Moon, Soo Lim, Hak Chul Jang, Kyong Soo Park, Young Min Cho
SJR Q1Diabetes Care

OBJECTIVE This study evaluated the efficacy of a smartphone-based, patient-centered diabetes care system (mDiabetes) for type 2 diabetes that contains comprehensive modules for glucose monitoring, diet, physical activity, and a clinical decision support system. RESEARCH DESIGN AND METHODS We conducted a 24-week, multicenter, randomized controlled trial with adult patients with inadequately controlled type 2 diabetes. The patients were randomly assigned to the mDiabetes group or the paper logbook

Endocrinology, Diabetes and MetabolismMedicine
14
Article|65 citations·2004
Disruption of cell?cell contact maximally but transiently activates AhR-mediated transcription in 10T1/2 fibroblasts*1
Young Min Cho
SJR Q2Toxicology and Applied Pharmacology
Health, Toxicology and MutagenesisEnvironmental Science
15
Article|63 citations·2005
Array comparative genomic hybridization analysis of uterine leiomyosarcoma
Young Min Cho, Sung Min Bae, M Koo, Kyung‐Hee Kim, Heung Jae Chun, Cheorl‐Ho Kim, Duck Yeong Ro, Jong‐Hoon Kim, Charles Lee, Yeul Hong Kim
SJR Q1Gynecologic Oncology
Obstetrics and GynecologyMedicine

Research Areas

Endocrinology, Diabetes and MetabolismSurgeryMolecular BiologyGeneticsEpidemiologyPhysiology

Young Min Choの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。